Baxter Vaccine AG
3Patents
0Active
3Granted
26Portfolio score
Filing activity: Apr 29, 1994 → Jan 12, 1999
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6486130B1 | Immunogenic formulation of OSPC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6872550B1 | Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6352856B1 | Chimeric poxvirus comprising sequences of a retroviral vector component | Chemistry; Metallurgy | 7 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.